Skip to main content

Table 4 Mean pain VAS score determined throughout the observation period in both groups

From: Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

 

Control

Study

P value

Day-0

5.4 ± 1.7

5.3 ± 1.6

>0.05

Day-1

5 ± 1.3

4.3 ± 1.3a

0.045

Day-2

4.9 ± 1.8

3.6 ± 1a

0.003

Day-3

4.6 ± 1.8

2.3 ± 1.8a

0.001

Day-4

4.5 ± 1.4

1.6 ± 1.2a

0.001

Day-5

3.7 ± 2a

0.92 ± 1.1a

0.001

Day-6

2.4 ± 1.1a

0.33 ± 0.6a

0.001

Day-7

1.6 ± 1.1a

0.17 ± 0.38a

0.001

Day-8

1.1 ± 1.7a

0.13 ± 0.34a

0.001

  1. Data are presented as mean (±SD); Day-0: time of enrolment; a: significant difference versus respective Day-0 data; P value for the difference between both groups
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us